VieCuri Medisch Centrum

Futó vizsgálatok

• Fut, nem toboroz

  Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

  NCT07037433· 3. fázis· Amgen· Forrás

• Toboroz

  Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  NCT07037459· 3. fázis· Amgen· Forrás

• Fut, nem toboroz

  Clinical Study to Predict the Risk of Bone Fractures With the POROUS Ultrasound Device

  NCT06567054· POROUS GmbH· Forrás

• Toboroz

  Optimizing Recovery After Reverse Shoulder Arthroplasty With a Personalized Mobile Health Application

  NCT06520085· VieCuri Medical Centre· Forrás

• Fut, nem toboroz

  The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

  NCT06383390· 3. fázis· Eli Lilly and Company· Forrás

• Toboroz

  Apa/Enza-short Study: Shorter Treatment With Androgen Receptor Pathway Inhibitor in Patients With Low-volume Metastatic Castration-sensitive Prostate Cancer

  NCT07260435· 3. fázis· Nick Beije· Forrás

• Toboroz

  Multi-parametric MRI in Patients Suspected for Muscle Invasive Bladder Cancer: a New Local Staging Paradigm

  NCT05779631· Radboud University Medical Center· Forrás

• Fut, nem toboroz

  Enlicitide Decanoate (MK-0616 Oral PCSK9 Inhibitor) Cardiovascular Outcomes Study (MK-0616-015) CORALreef Outcomes

  NCT06008756· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Fut, nem toboroz

  SEQUence of Endocrine Therapy in Advanced Luminal Breast Cancer (SEQUEL-Breast)

  NCT05392608· 2. fázis· Borstkanker Onderzoek Groep· Forrás

• Fut, nem toboroz

  A Phase 3 Study of Zalunfiban in Subjects With ST-elevation MI

  NCT04825743· 3. fázis· CeleCor Therapeutics· Forrás

• Meghívásos bevonás

  The NetherLands Registry of Invasive Coronary Vasomotor Function Testing (NL-CFT)

  NCT06083155· Radboud University Medical Center· Forrás

• Toboroz

  Circulating Tumor DNA Based Adjuvant Chemotherapy in Stage II Colon Cancer Patients: the MEDOCC-CrEATE Trial

  NCT06434896· UMC Utrecht· Forrás

• Fut, nem toboroz

  FFR Driven Complete Revascularization Versus Usual Care in NSTEMI Patients and Multivessel Disease

  NCT03562572· Zuyderland Medisch Centrum· Forrás

• Fut, nem toboroz

  Multicentric Randomised Trial for Resectable Gastric Cancer

  NCT02931890· 2. fázis· The Netherlands Cancer Institute· Forrás

• Fut, nem toboroz

  A Trial of Aspirin on Recurrence and Survival in Colon Cancer Patients

  NCT02301286· 3. fázis· Leiden University· Forrás

• Toboroz

  Prospective Data Collection Initiative on Colorectal Cancer

  NCT02070146· Dutch Colorectal Cancer Group· Forrás

Egyszerre toboroz

Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.

• Vastagbélrák2 toboroz
• Elhízás1 toboroz
• Hólyagrák1 toboroz
• Koszorúér-betegség1 toboroz
• Osteoarthritis1 toboroz
• Prosztatarák1 toboroz
• Szívelégtelenség1 toboroz

Lezárt vizsgálatok

• Lezárult

  Randomized Study to Evaluate the Effect of Obicetrapib on Top of Maximum Tolerated Lipid-Modifying Therapies

  NCT05142722· 3. fázis· NewAmsterdam Pharma· Forrás

• Lezárult

  Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7080) in Urothelial Carcinoma Cisplatin-ineligible Participants Whose Tumors Express Programmed Cell Death-Ligand 1 and in Participants Ineligible for Platinum-containing Chemotherapy (MK-7902-011/E7080-G000-317/ LEAP-011)

  NCT03898180· 3. fázis· Merck Sharp & Dohme LLC· Forrás

• Lezárult

  Treatment Strategies in Colorectal Cancer Patients With Initially Unresectable Liver-only Metastases

  NCT02162563· 3. fázis· Dutch Colorectal Cancer Group· Forrás

Betegségek

Betegségek, amelyekről az intézmény publikál vagy amelyekre vizsgálatot futtat.

• Gout5 munka · 0 vizsgálat